Published • loading... • Updated
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
Summary by The Record
6 Articles
6 Articles
Cambridge Times+5 Reposted by 5 other sources
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
BROSSARD, Quebec, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce…
·Cambridge, Canada
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left4Leaning Right1Center1Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 17%
R 16%
Factuality
To view factuality data please Upgrade to Premium
